当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 现金流量表

金陵药业

(000919)

  

流通市值:41.41亿  总市值:41.42亿
流通股本:6.22亿   总股本:6.22亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,723,540,942.37749,750,020.673,270,504,012.572,404,911,633.73
  收到的税费返还00642,060.750
  收到其他与经营活动有关的现金30,510,544.6813,437,298.4528,320,009.9350,393,090.08
  经营活动现金流入小计1,754,051,487.05763,187,319.123,299,466,083.252,455,304,723.81
  购买商品、接受劳务支付的现金741,017,945.7375,637,414.761,628,792,195.611,226,370,242.59
  支付给职工以及为职工支付的现金616,252,905.54323,516,968.081,164,775,088.69927,518,392.47
  支付的各项税费62,670,750.7728,475,389.35102,950,609.4180,399,800.95
  支付其他与经营活动有关的现金86,719,153.7536,605,306.62228,738,940.41131,724,010.21
  经营活动现金流出小计1,506,660,755.76764,235,078.813,125,256,834.122,366,012,446.22
  经营活动产生的现金流量净额247,390,731.29-1,047,759.69174,209,249.1389,292,277.59
二、投资活动产生的现金流量:
  收回投资收到的现金339,143,503.04127,295,075.71,146,410,563.81964,576,925.6
  取得投资收益收到的现金5,646,467.381,988,519.9937,129,993.6116,537,266.59
  处置固定资产、无形资产和其他长期资产收回的现金净额6,828,303.956,569,011120,522.01189,883.32
  投资活动现金流入小计351,618,274.37135,852,606.691,183,661,079.43981,304,075.51
  购建固定资产、无形资产和其他长期资产支付的现金47,235,571.479,574,584.72157,867,056.5985,894,086.64
  投资支付的现金635,018,060.98431,343,089.731,335,200,0001,479,200,000
  投资活动现金流出小计682,253,632.45440,917,674.451,493,067,056.591,565,094,086.64
  投资活动产生的现金流量净额-330,635,358.08-305,065,067.76-309,405,977.16-583,790,011.13
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金65,485,613.581,558,501.477,729,031.6476,394,152.34
  其中:子公司支付给少数股东的股利、利润1,727,251.4677,251.410,214,127.396,650,000
  支付其他与筹资活动有关的现金712,755.0607,347,041.546,075,789
  筹资活动现金流出小计66,198,368.641,558,501.485,076,073.1882,469,941.34
  筹资活动产生的现金流量净额-66,198,368.64-1,558,501.4-85,076,073.18-82,469,941.34
四、汇率变动对现金及现金等价物的影响-32,399.24-6,356.948,450.5610,367.79
五、现金及现金等价物净增加额-149,475,394.67-307,677,685.79-220,264,350.65-576,957,307.09
  加:期初现金及现金等价物余额1,361,103,616.771,361,103,616.771,581,367,967.421,581,367,967.42
  期末现金及现金等价物余额1,211,628,222.11,053,425,930.981,361,103,616.771,004,410,660.33
补充资料:
  净利润55,979,155.13-51,292,285.96-
  资产减值准备-3,723,683.97-8,748,466.31-
  固定资产和投资性房地产折旧56,156,018.93-134,621,180.99-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧56,156,018.93-134,621,180.99-
  无形资产摊销8,520,344.56-21,886,650.43-
  长期待摊费用摊销6,446,097.52-12,546,129.66-
  处置固定资产、无形资产和其他长期资产的损失-4,830,130.71-387,493.74-
  固定资产报废损失301,177.17-912,072.1-
  公允价值变动损失4,972,798.5-108,568.42-
  财务费用2,503,500.85--4,063,493.49-
  投资损失-8,312,706.54--30,195,899.89-
  递延所得税-3,874,034.18--2,381,419.59-
  其中:递延所得税资产减少-1,472,729.6--115,580-
    递延所得税负债增加-2,401,304.58--2,265,839.59-
  存货的减少44,576,953.37-37,462,117.21-
  经营性应收项目的减少96,215,810.65-5,120,409.92-
  经营性应付项目的增加-8,174,275.41--63,486,643.38-
  其他---3,458,083.53-
  现金的期末余额1,211,628,222.1-1,361,103,616.77-
  减:现金的期初余额1,361,103,616.77-1,581,367,967.42-
  现金及现金等价物的净增加额-149,475,394.67--220,264,350.65-
公告日期2026-08-292026-04-282026-03-312025-10-28
审计意见(境内)标准无保留意见
TOP↑